$ROIV
Roivant Sciences Ltd. Stock $roiv

$roiv Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000114036123031798 Filed on June 28, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2023
Revenue	$21.62M	$61.28M	$61.28M
YoY Change	400.67%	564.43%	10.84%
Cost Of Revenue	$4.214M	$13.13M	$13.13M
YoY Change	144.15%	2760.13%	46.42%
Gross Profit	$17.41M	$48.15M	$48.15M
YoY Change	571.42%	449.43%	3.96%
Gross Profit Margin	80.51%	78.58%	78.58%
Selling, General & Admin	$156.2M	$600.5M	$600.5M
YoY Change	4.77%	332.1%	-22.52%
% of Gross Profit	897.13%	1247.11%	1247.11%
Research & Development	$125.1M	$623.0M	$525.2M
YoY Change	-7.88%	356.07%	-15.69%
% of Gross Profit	718.74%	1293.74%	1090.74%
Depreciation & Amortization	$5.839M	$5.953M	$18.86M
YoY Change	118.04%		217.89%
% of Gross Profit	33.54%	12.36%	39.16%
Operating Expenses	$298.0M	$1.223B	$1.237B
YoY Change	3.98%	343.98%	-11.54%
Operating Profit	-$276.4M	-$1.175B	-$1.175B
YoY Change	-2.09%	340.52%	-13.05%
Interest Expense	$8.912M	-$16.60M	$27.97M
YoY Change	241.19%	-77.63%	-92.0%
% of Operating Profit
Other Income/Expense, Net	$4.593M	-$62.19M	$15.81M
YoY Change	-367.66%	-239.76%	139.84%
Pretax Income	-$326.1M	-$1.225B	-$1.225B
YoY Change	-6.77%	320.22%	32.59%
Income Tax	$1.752M	$5.190M	$5.190M
% Of Pretax Income
Net Earnings	-$291.8M	-$1.009B	-$1.009B
YoY Change	-12.05%	273.63%	9.19%
Net Earnings / Revenue	-1349.5%	-1646.59%	-1646.59%
Basic Earnings Per Share	-$0.38		-$1.42
Diluted Earnings Per Share	-$0.38	-$1.41	-$1.42
COMMON SHARES
Basic Shares Outstanding	766.8M	758.4M	712.8M
Diluted Shares Outstanding	759.3M		712.8M

Balance Sheet

Concept	2023 Q2	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.434B	$1.677B	$1.677B
YoY Change	-26.16%	-18.62%	-18.62%
Cash & Equivalents	$1.434B	$1.677B	$1.677B
Short-Term Investments
Other Short-Term Assets	$127.1M	$121.8M	$121.8M
YoY Change	36.23%	48.11%	41.4%
Inventory	$4.225M	$2.761M	$2.761M
Prepaid Expenses	$64.66M	$60.83M
Receivables	$37.06M	$30.38M	$30.38M
Other Receivables	$2.850M	$2.356M	$2.356M
Total Short-Term Assets	$1.561B	$1.799B	$1.799B
YoY Change	-23.45%	-16.21%	-16.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$36.27M	$39.09M	$92.34M
YoY Change	14.46%	50.88%	6.2%
Goodwill
YoY Change
Intangibles	$145.0M	$144.9M
YoY Change	-0.27%
Long-Term Investments	$296.2M	$304.3M	$304.3M
YoY Change	-1.67%	-6.6%	-6.6%
Other Assets	$46.31M	$49.48M	$49.48M
YoY Change	261.21%	207.49%	91.62%
Total Long-Term Assets	$575.5M	$591.0M	$591.0M
YoY Change	2.59%	34.75%	34.75%
TOTAL ASSETS
Total Short-Term Assets	$1.561B	$1.799B	$1.799B
Total Long-Term Assets	$575.5M	$591.0M	$591.0M
Total Assets	$2.137B	$2.390B	$2.390B
YoY Change	-17.83%	-7.56%	-7.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$50.04M	$37.83M	$37.83M
YoY Change	-68.98%	9.39%	9.39%
Accrued Expenses	$119.3M	$167.1M	$178.8M
YoY Change	9.12%	31.05%	28.71%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$44.41M	$40.72M	$42.81M
YoY Change	33.34%
Total Short-Term Liabilities	$245.0M	$272.4M	$272.4M
YoY Change	-25.51%	47.77%	47.77%
LONG-TERM LIABILITIES
Long-Term Debt	$385.1M	$375.5M	$379.1M
YoY Change	0.35%	78.8%	80.5%
Other Long-Term Liabilities	$16.90M	$17.03M	$130.5M
YoY Change	107.12%	108.14%	0.91%
Total Long-Term Liabilities	$16.90M	$17.03M	$509.6M
YoY Change	107.12%	108.14%	50.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$245.0M	$272.4M	$272.4M
Total Long-Term Liabilities	$16.90M	$17.03M	$509.6M
Total Liabilities	$802.5M	$782.0M	$1.232B
YoY Change	-2.43%	49.33%	32.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.100B	-$3.800B
YoY Change	32.26%	37.5%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$910.7M	$1.158B	$1.158B
YoY Change
Total Liabilities & Shareholders Equity	$2.137B	$2.390B	$2.390B
YoY Change	-17.83%	-7.56%	-7.56%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	-$291.8M	-$1.009B	-$1.009B
YoY Change	-12.05%	273.63%	9.19%
Depreciation, Depletion And Amortization	$5.839M	$5.953M	$18.86M
YoY Change	118.04%		217.89%
Cash From Operating Activities	-$249.9M	-$179.1M	-$843.4M
YoY Change	-0.85%	21.44%	24.44%
INVESTING ACTIVITIES
Capital Expenditures	$403.0K	$1.622M	$12.69M
YoY Change	-94.6%	-125.9%	-172.78%
Acquisitions
YoY Change
Other Investing Activities	-$508.0K	$115.2M	-$702.0K
YoY Change		20430.3%	-100.22%
Cash From Investing Activities	$105.0K	$113.6M	-$44.27M
YoY Change	-101.41%	-2091.46%	-114.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$312.0M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	7.477M	210.3M	499.5M
YoY Change	-94.73%	19557.2%	62.8%
NET CHANGE
Cash From Operating Activities	-249.9M	-179.1M	-843.4M
Cash From Investing Activities	105.0K	113.6M	-44.27M
Cash From Financing Activities	7.477M	210.3M	499.5M
Net Change In Cash	-242.5M	144.8M	-381.9M
YoY Change	106.24%	-195.2%	464.62%
FREE CASH FLOW
Cash From Operating Activities	-$249.9M	-$179.1M	-$843.4M
Capital Expenditures	$403.0K	$1.622M	$12.69M
Free Cash Flow	-$250.3M	-$180.7M	-$856.1M
YoY Change	-3.55%	27.98%	29.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001635088
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2023Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023	dei	Auditor Firm AuditorFirmId	42
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40782
CY2023	dei	Entity Registrant Name EntityRegistrantName	ROIVANT SCIENCES LTD.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1173944
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	7th Floor
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	50 Broadway
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	London
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	SW1H 0BD
CY2023	dei	Entity Address Country EntityAddressCountry	GB
CY2023	dei	Country Region CountryRegion	44
CY2023	dei	City Area Code CityAreaCode	207
CY2023	dei	Local Phone Number LocalPhoneNumber	400 3347
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	445200000
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	766811433
CY2023	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2023	dei	Auditor Location AuditorLocation	Iselin, New Jersey
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1676813000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2060400000
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	121774000
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	86123000
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1798587000
CY2022Q1	us-gaap	Assets Current AssetsCurrent	2146523000
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39086000
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25905000
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	53251000
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	61044000
CY2023Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	304317000
CY2022Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	325834000
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	144881000
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	49482000
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25823000
CY2023Q1	us-gaap	Assets Assets	2389604000
CY2022Q1	us-gaap	Assets Assets	2585129000
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	37830000
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	34583000
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	167129000
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	127531000
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11693000
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11398000
CY2023Q1	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	26940000
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	40720000
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	0
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15076000
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10855000
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	272448000
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	184367000
CY2023Q1	roiv	Liability Instruments Measured At Fair Value LiabilityInstrumentsMeasuredAtFairValue	63546000
CY2022Q1	roiv	Liability Instruments Measured At Fair Value LiabilityInstrumentsMeasuredAtFairValue	44912000
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	53476000
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	62468000
CY2023Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	180700000
CY2022Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	177400000
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	375515000
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	210025000
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17032000
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	21923000
CY2023Q1	us-gaap	Liabilities Liabilities	782017000
CY2022Q1	us-gaap	Liabilities Liabilities	523695000
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0
CY2022Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	22491000
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0000000341740141
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0000000341740141
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	7000000000
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	7000000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	760143393
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	760143393
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	694975965
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	694975965
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	0
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	0
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4933137000
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4421614000
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3772754000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2763724000
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2617000
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-946000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1157766000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1656944000
CY2023Q1	us-gaap	Minority Interest MinorityInterest	449821000
CY2022Q1	us-gaap	Minority Interest MinorityInterest	381999000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1607587000
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2038943000
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2389604000
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2585129000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	61280000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55286000
CY2023	roiv	Operating Costs OperatingCosts	13128000
CY2022	roiv	Operating Costs OperatingCosts	8966000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	525215000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	483035000
CY2023	roiv	Acquired In Process Research And Development Expense AcquiredInProcessResearchAndDevelopmentExpense	97749000
CY2022	roiv	Acquired In Process Research And Development Expense AcquiredInProcessResearchAndDevelopmentExpense	139894000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	600506000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	775033000
CY2023	us-gaap	Operating Expenses OperatingExpenses	1236598000
CY2022	us-gaap	Operating Expenses OperatingExpenses	1406928000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1175318000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1351642000
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-20815000
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-87291000
CY2023	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	0
CY2022	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	443754000
CY2023	roiv	Gain Loss On Fair Value Of Debt And Liability Instruments GainLossOnFairValueOfDebtAndLiabilityInstruments	-78001000
CY2022	roiv	Gain Loss On Fair Value Of Debt And Liability Instruments GainLossOnFairValueOfDebtAndLiabilityInstruments	3354000
CY2023	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0
CY2022	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	66472000
CY2023	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	29276000
CY2022	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	5041000
CY2023	roiv	Interest Income InterestIncome	32184000
CY2022	roiv	Interest Income InterestIncome	369000
CY2023	us-gaap	Interest Expense InterestExpense	27968000
CY2022	us-gaap	Interest Expense InterestExpense	7041000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	15808000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3237000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1224834000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-923747000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5190000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	369000
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1230024000
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-924116000
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	114561000
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0
CY2023	us-gaap	Profit Loss ProfitLoss	-1115463000
CY2022	us-gaap	Profit Loss ProfitLoss	-924116000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-106433000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-78854000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1009030000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-845262000
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1123591000
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-845262000
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	114561000
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1009030000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-845262000
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.58
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.58
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.26
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.26
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.16
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.16
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.42
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.42
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.26
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.26
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	712791115
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	669753458
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	712791115
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	669753458
CY2023	us-gaap	Profit Loss ProfitLoss	-1115463000
CY2022	us-gaap	Profit Loss ProfitLoss	-924116000
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1490000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-2271000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1490000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2271000
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1116953000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-926387000
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-106252000
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-78734000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1010701000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-847653000
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2039514000
CY2022	roiv	Issuance Of Subsidiary Warrants Value IssuanceOfSubsidiaryWarrantsValue	2075000
CY2022	roiv	Stock Issued During Period Value Common Shares Upon Closing Of Business Combination And Pipe Financing StockIssuedDuringPeriodValueCommonSharesUponClosingOfBusinessCombinationAndPipeFinancing	-129097000
CY2022	roiv	Stock Issued During Period Value Common Shares Related To Settlement Of Transaction Consideration StockIssuedDuringPeriodValueCommonSharesRelatedToSettlementOfTransactionConsideration	0
CY2022	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	70000000
CY2022	roiv	Stock Issued During Period Value Subsidiary Common And Preferred Shares And Cash Contribution To Majority Owned Subsidiaries StockIssuedDuringPeriodValueSubsidiaryCommonAndPreferredSharesAndCashContributionToMajorityOwnedSubsidiaries	0
CY2022	roiv	Adjustments Of Payment Of Subscription Receivable Value AdjustmentsOfPaymentOfSubscriptionReceivableValue	-100000000
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2247000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	57167000
CY2022	roiv	Stock Issued During Period Value Warrants Exercise StockIssuedDuringPeriodValueWarrantsExercise	778000
CY2022	roiv	Stock Issued During Period Value Stock Options Exercised And Restricted Stock Units Vested And Settled StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockUnitsVestedAndSettled	412000
CY2022	roiv	Noncontrolling Interest Increase Decrease From Deconsolidation NoncontrollingInterestIncreaseDecreaseFromDeconsolidation	-3578000
CY2022	roiv	Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition	564956000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2271000
CY2022	us-gaap	Profit Loss ProfitLoss	-924116000
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2038943000
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	311683000
CY2023	roiv	Stock Issued During Period Value In Connection With Equity Incentive Plans And Tax Withholding Payments StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansAndTaxWithholdingPayments	8737000
CY2023	roiv	Stock Issued During Period Value Common Shares Related To Settlement Of Transaction Consideration StockIssuedDuringPeriodValueCommonSharesRelatedToSettlementOfTransactionConsideration	0
CY2023	roiv	Stock Issued During Period Common Shares And Other Consideration For Acquisition Value StockIssuedDuringPeriodCommonSharesAndOtherConsiderationForAcquisitionValue	8948000
CY2023	roiv	Stock Issued During Period Value Subsidiary Common And Preferred Shares And Cash Contribution To Majority Owned Subsidiaries StockIssuedDuringPeriodValueSubsidiaryCommonAndPreferredSharesAndCashContributionToMajorityOwnedSubsidiaries	0
CY2023	roiv	Issuance Of Subsidiary Common Shares To The Company Value IssuanceOfSubsidiaryCommonSharesToTheCompanyValue	67728000
CY2023	roiv	Stock Issued During Period Value Subsidiary Stock Options Exercised StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised	670000
CY2023	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	87500000
CY2023	roiv	Noncontrolling Interest Increase Decrease From Deconsolidation NoncontrollingInterestIncreaseDecreaseFromDeconsolidation	292000
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	316000
CY2023	roiv	Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition	217781000
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1490000
CY2023	us-gaap	Profit Loss ProfitLoss	-1115463000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1607587000
CY2023	us-gaap	Profit Loss ProfitLoss	-1115463000
CY2022	us-gaap	Profit Loss ProfitLoss	-924116000
CY2023	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	87749000
CY2022	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	78223000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	217781000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	564956000
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-20815000
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-87291000
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	443754000
CY2023	roiv	Gain Loss On Fair Value Of Debt And Liability Instruments GainLossOnFairValueOfDebtAndLiabilityInstruments	-78001000
CY2022	roiv	Gain Loss On Fair Value Of Debt And Liability Instruments GainLossOnFairValueOfDebtAndLiabilityInstruments	3354000
CY2023	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	29276000
CY2022	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	5041000
CY2023	roiv	Gain On Termination Of Equity Interest Options GainOnTerminationOfEquityInterestOptions	0
CY2022	roiv	Gain On Termination Of Equity Interest Options GainOnTerminationOfEquityInterestOptions	61472000
CY2023	roiv	Gain Loss On Recovery Of Contingent Consideration Discontinued Operations GainLossOnRecoveryOfContingentConsiderationDiscontinuedOperations	114561000
CY2022	roiv	Gain Loss On Recovery Of Contingent Consideration Discontinued Operations GainLossOnRecoveryOfContingentConsiderationDiscontinuedOperations	0
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18857000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5932000
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	7565000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	7270000
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	21206000
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-617000
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	31670000
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	27999000
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	4359000
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	15403000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	38956000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	50595000
CY2023	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	0
CY2022	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-50000000
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-8604000
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-6865000
CY2023	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-3304000
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-34585000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-843393000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-677729000
CY2023	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	6706000
CY2022	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	39000
CY2023	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	320170000
CY2023	roiv	Proceeds From Sale Of Top Up Shares Discontinued Operations ProceedsFromSaleOfTopUpSharesDiscontinuedOperations	114561000
CY2022	roiv	Proceeds From Sale Of Top Up Shares Discontinued Operations ProceedsFromSaleOfTopUpSharesDiscontinuedOperations	0
CY2023	roiv	Milestone Payments MilestonePayments	140136000
CY2022	roiv	Milestone Payments MilestonePayments	0
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12690000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17436000
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-702000
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-600000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-44269000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	303295000
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	311981000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2023	roiv	Proceeds From Business Combination And Pipe Financing ProceedsFromBusinessCombinationAndPIPEFinancing	0
CY2022	roiv	Proceeds From Business Combination And Pipe Financing ProceedsFromBusinessCombinationAndPIPEFinancing	213424000
CY2023	roiv	Proceeds From Issuance Of Subsidiary Common Shares Net ProceedsFromIssuanceOfSubsidiaryCommonSharesNet	67727000
CY2022	roiv	Proceeds From Issuance Of Subsidiary Common Shares Net ProceedsFromIssuanceOfSubsidiaryCommonSharesNet	0
CY2023	roiv	Proceeds From Payment Of Subscription Receivable ProceedsFromPaymentOfSubscriptionReceivable	0
CY2022	roiv	Proceeds From Payment Of Subscription Receivable ProceedsFromPaymentOfSubscriptionReceivable	100000000
CY2023	roiv	Proceeds From Subsidiary Debt Financings Net ProceedsFromSubsidiaryDebtFinancingsNet	159899000
CY2022	roiv	Proceeds From Subsidiary Debt Financings Net ProceedsFromSubsidiaryDebtFinancingsNet	36400000
CY2023	roiv	Repayment Of Long Term Debt And Convertible Debt By Subsidiary RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary	29452000
CY2022	roiv	Repayment Of Long Term Debt And Convertible Debt By Subsidiary RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary	21590000
CY2023	roiv	Payment For Offering And Loan Costs PaymentForOfferingAndLoanCosts	2250000
CY2022	roiv	Payment For Offering And Loan Costs PaymentForOfferingAndLoanCosts	20297000
CY2023	roiv	Payments Of Taxes For The Repurchase Of Equity PaymentsOfTaxesForTheRepurchaseOfEquity	10881000
CY2022	roiv	Payments Of Taxes For The Repurchase Of Equity PaymentsOfTaxesForTheRepurchaseOfEquity	0
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2814000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	412000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	692000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	316000
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1557000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	499462000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	306792000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6281000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-381919000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-67642000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2074034000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2141676000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1692115000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2074034000
CY2023	roiv	Common Shares And Other Consideration Issued For Purchase Of Property And Equipment CommonSharesAndOtherConsiderationIssuedForPurchaseOfPropertyAndEquipment	9694000
CY2022	roiv	Common Shares And Other Consideration Issued For Purchase Of Property And Equipment CommonSharesAndOtherConsiderationIssuedForPurchaseOfPropertyAndEquipment	0
CY2023	roiv	Noncash Other NoncashOther	10860000
CY2022	roiv	Noncash Other NoncashOther	6035000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5128000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	916000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	5303000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	5535000
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1700000000
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3800000000
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1200000000
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-924100000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.014
CY2023	roiv	Effective Income Tax Rate Reconciliation Permanent Adjustments Amount EffectiveIncomeTaxRateReconciliationPermanentAdjustmentsAmount	13314000
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1676813000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2060400000
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	5011000
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	3903000
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	10291000
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	9731000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1692115000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2074034000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.1938
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	17714000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	-0.0145
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	15347000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	-0.0166
CY2023	roiv	Effective Income Tax Rate Reconciliation Changes In Fair Value Of Investments And Loss From Equity Method Investment EffectiveIncomeTaxRateReconciliationChangesInFairValueOfInvestmentsAndLossFromEquityMethodInvestment	4118000
CY2023	roiv	Effective Income Tax Rate Reconciliation Changes In Fair Value Of Investments And Loss From Equity Method Investment Percent EffectiveIncomeTaxRateReconciliationChangesInFairValueOfInvestmentsAndLossFromEquityMethodInvestmentPercent	-0.0034
CY2022	roiv	Effective Income Tax Rate Reconciliation Changes In Fair Value Of Investments And Loss From Equity Method Investment EffectiveIncomeTaxRateReconciliationChangesInFairValueOfInvestmentsAndLossFromEquityMethodInvestment	15169000
CY2022	roiv	Effective Income Tax Rate Reconciliation Changes In Fair Value Of Investments And Loss From Equity Method Investment Percent EffectiveIncomeTaxRateReconciliationChangesInFairValueOfInvestmentsAndLossFromEquityMethodInvestmentPercent	-0.0164
CY2023	us-gaap	Income Tax Reconciliation Disposition Of Assets IncomeTaxReconciliationDispositionOfAssets	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0
CY2022	us-gaap	Income Tax Reconciliation Disposition Of Assets IncomeTaxReconciliationDispositionOfAssets	-84313000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0.0913
CY2023	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y7M6D
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	152629000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7748000
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	144881000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9300000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	9300000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	9300000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	9300000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9300000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	98400000
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	60827000
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	53370000
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	30379000
CY2022Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	3878000
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	5011000
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	3903000
CY2023Q1	us-gaap	Inventory Net InventoryNet	2761000
CY2022Q1	us-gaap	Inventory Net InventoryNet	0
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2356000
CY2022Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2854000
CY2023Q1	roiv	Other Of Other Assets Current OtherOfOtherAssetsCurrent	20440000
CY2022Q1	roiv	Other Of Other Assets Current OtherOfOtherAssetsCurrent	22118000
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	121774000
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	86123000
CY2023	us-gaap	Income Tax Reconciliation Disposition Of Business IncomeTaxReconciliationDispositionOfBusiness	-2378000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0.0019
CY2022	us-gaap	Income Tax Reconciliation Disposition Of Business IncomeTaxReconciliationDispositionOfBusiness	-958000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0.001
CY2023Q1	roiv	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	76278000
CY2022Q1	roiv	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	66188000
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	55186000
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	44262000
CY2023Q1	roiv	Accrued Sales Allowances Current AccruedSalesAllowancesCurrent	17569000
CY2022Q1	roiv	Accrued Sales Allowances Current AccruedSalesAllowancesCurrent	0
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18096000
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	17081000
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	167129000
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	127531000
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	12444000
CY2022Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10147000
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	542000
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	708000
CY2023Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	2090000
CY2022Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	0
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15076000
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10855000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	20558000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0168
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	25973000
CY2023	roiv	Number Of Equity Incentive Plans NumberOfEquityIncentivePlans	3
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0281
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	3311000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.0027
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	12918000
CY2023	roiv	Share Based Payment Arrangement Award Modification Expense ShareBasedPaymentArrangementAwardModificationExpense	20800000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1224834000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-923747000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5190000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	369000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5190000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	369000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-208440000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.1702
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-179000000
CY2023	roiv	Effective Income Tax Rate Reconciliation Other Permanent Adjustments Percent EffectiveIncomeTaxRateReconciliationOtherPermanentAdjustmentsPercent	-0.0109
CY2022	roiv	Effective Income Tax Rate Reconciliation Permanent Adjustments Amount EffectiveIncomeTaxRateReconciliationPermanentAdjustmentsAmount	10912000
CY2022	roiv	Effective Income Tax Rate Reconciliation Other Permanent Adjustments Percent EffectiveIncomeTaxRateReconciliationOtherPermanentAdjustmentsPercent	-0.0118
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	14487000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0118
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	10113000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0109
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	157197000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1283
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	205811000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2228
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	2771000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0022
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-2444000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0026
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	11512000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0093
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-8933000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0097
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5190000
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0042
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	369000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0004
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0042
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0004
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	37559000
CY2022Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	27155000
CY2023Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	52857000
CY2022Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	61544000
CY2023Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	37252000
CY2022Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	0
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	422613000
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	312749000
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	105343000
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	93177000
CY2023Q1	roiv	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	15521000
CY2022Q1	roiv	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	15406000
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	25959000
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	20651000
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	697104000
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	530682000
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	674517000
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	512736000
CY2023Q1	roiv	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	1798000
CY2022Q1	roiv	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	1397000
CY2023Q1	roiv	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	12959000
CY2022Q1	roiv	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	12661000
CY2023Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	7830000
CY2022Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3888000
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	674500000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	161800000
CY2022Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	12045000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	13649000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1623000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	326000
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	2151000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	1227000
CY2023	roiv	Operating Lease Costs OperatingLeaseCosts	15819000
CY2022	roiv	Operating Lease Costs OperatingLeaseCosts	15202000
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	454000
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	102000
CY2023	roiv	Finance Lease Cost FinanceLeaseCost	556000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	13109000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	14403000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4224000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6035000
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	61000
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	0
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	692000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	6338000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y4M24D
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M6D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.079
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.083
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5885000
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2090000
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3574000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	13588000
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2199000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	11425000
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2119000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	10279000
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1730000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9488000
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	252000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	9515000
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	168000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	43107000
CY2023Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	97402000
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	6468000
CY2023Q1	roiv	Operating Lease Liability Present Value Adjustments OperatingLeaseLiabilityPresentValueAdjustments	27021000
CY2023Q1	roiv	Finance Lease Liability Present Value Adjustments FinanceLeaseLiabilityPresentValueAdjustments	804000
CY2023Q1	roiv	Lessee Operating Lease Liability Tenant Improvement Allowance LesseeOperatingLeaseLiabilityTenantImprovementAllowance	5212000
CY2023Q1	roiv	Lessee Finance Lease Liability Tenant Improvement Allowance LesseeFinanceLeaseLiabilityTenantImprovementAllowance	0
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	65169000
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	5664000

Files In Submission

Name	View Source	Status
0001140361-23-031798-index-headers.html	Edgar Link	pending
0001140361-23-031798-index.html	Edgar Link	pending
0001140361-23-031798.txt	Edgar Link	pending
0001140361-23-031798-xbrl.zip	Edgar Link	pending
brhc20054745_10k.htm	Edgar Link	pending
brhc20054745_ex10-27.htm	Edgar Link	pending
brhc20054745_ex10-39.htm	Edgar Link	pending
brhc20054745_ex10-40.htm	Edgar Link	pending
brhc20054745_ex10-41.htm	Edgar Link	pending
brhc20054745_ex10-42.htm	Edgar Link	pending
brhc20054745_ex10-43.htm	Edgar Link	pending
brhc20054745_ex10-44.htm	Edgar Link	pending
brhc20054745_ex10-45.htm	Edgar Link	pending
brhc20054745_ex21-1.htm	Edgar Link	pending
brhc20054745_ex23-1.htm	Edgar Link	pending
brhc20054745_ex31-1.htm	Edgar Link	pending
brhc20054745_ex31-2.htm	Edgar Link	pending
brhc20054745_ex32-1.htm	Edgar Link	pending
brhc20054745_ex32-2.htm	Edgar Link	pending
brhc20054745_ex4-5.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image0.jpg	Edgar Link	pending
image00023.jpg	Edgar Link	pending
image00024.jpg	Edgar Link	pending
image00025.jpg	Edgar Link	pending
image00026.jpg	Edgar Link	pending
image00027.jpg	Edgar Link	pending
image1.jpg	Edgar Link	pending
image10.jpg	Edgar Link	pending
image11.jpg	Edgar Link	pending
image12.jpg	Edgar Link	pending
image14.jpg	Edgar Link	pending
image15.jpg	Edgar Link	pending
image17.jpg	Edgar Link	pending
image18.jpg	Edgar Link	pending
image19.jpg	Edgar Link	pending
image2.jpg	Edgar Link	pending
image20.jpg	Edgar Link	pending
image21.jpg	Edgar Link	pending
image22.jpg	Edgar Link	pending
image3.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
brhc20054745_10k_htm.xml	Edgar Link	completed
image4.jpg	Edgar Link	pending
image5.jpg	Edgar Link	pending
image6.jpg	Edgar Link	pending
image7.jpg	Edgar Link	pending
image8.jpg	Edgar Link	pending
image9.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
roiv-20230331.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
roiv-20230331_cal.xml	Edgar Link	unprocessable
roiv-20230331_def.xml	Edgar Link	unprocessable
roiv-20230331_lab.xml	Edgar Link	unprocessable
roiv-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ROIV
Roivant Sciences Ltd. Stock $roiv

2023 Q2 Form 10-K Financial Statement

#000114036123031798 Filed on June 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ROIV Roivant Sciences Ltd. Stock $roiv

2023 Q2 Form 10-K Financial Statement

#000114036123031798 Filed on June 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ROIV
Roivant Sciences Ltd. Stock $roiv